Synthesis and biological evaluation of biaryl alkyl ethers as inhibitors of IDO1

Jay A. Markwalder(Bristol-Myers Squibb (Germany)), Steven P. Seitz(Bristol-Myers Squibb (Germany)), Yi Fan(Indiana University School of Medicine), David Critton(Bristol-Myers Squibb (United States)), H.A. Lewis(Princeton University), Tai-an Lin(Bristol-Myers Squibb (United States)), Dauh–Rurng Wu(Bristol-Myers Squibb (United States)), Yadagiri Kanyaboina(Bristol-Myers Squibb (India)), John A. Newitt(Bristol-Myers Squibb (United States)), Sarah C. Traeger(Bristol-Myers Squibb (United States)), Aaron Balog(Bristol-Myers Squibb (United States)), Michael Sinz(Rutgers, The State University of New Jersey), Susheel J. Nara(Bristol-Myers Squibb (India)), Xin Li(China Medical University), Chunhong Yan(Bristol-Myers Squibb (United States)), David Williams(Bristol-Myers Squibb (Germany)), Ratnakar Reddy(Bristol-Myers Squibb (India)), Saumya Roy(Bristol-Myers Squibb (United States)), Maria Jure–Kunkel(Bristol-Myers Squibb (United States)), Kathy Johnston(Bristol-Myers Squibb (United States)), Frank Marsilio(Bristol-Myers Squibb (United States)), Lata Jayaraman(Bristol-Myers Squibb (United States)), John T. Hunt(Bristol-Myers Squibb (United States))
Bioorganic & Medicinal Chemistry Letters
April 11, 2023
Cited by 7


Related Papers